Efficacy and tolerability of somatostatin analogues according to gender in patients with neuroendocrine tumors

RM Ruggeri, I Aini, S Gay, EM Grossrubatscher… - Reviews in Endocrine …, 2024 - Springer
As the incidence of neuroendocrine tumors has been rising, gender differences in
epidemiology and clinical behavior have emerged, and interest into a gender-driven …

[HTML][HTML] PET/CT imaging with radiolabeled FAPI: new opportunities for diagnosis and treatment of thyroid cancer

L Piscopo, F Volpe - European Journal of Nuclear Medicine and …, 2024 - Springer
Differentiated thyroid cancer (DTC) represents the most frequent endocrine neoplasm, with
an excellent prognosis [1]. After surgery, radioactive iodine (RAI) treatment remains a …

Metastatic castration-resistant prostate cancer therapy: the quest for the perfect molecule

D Bianco, C Nappi, M Klain - European Journal of Nuclear Medicine and …, 2024 - Springer
Prostate cancer (PC) is a common type of male malignancy with a high rate of diagnosis in
Western countries [1]. First line treatment for metastatic PC includes androgen deprivation …

Heterogeneity of Multiple Pancreatic Neuroendocrine Tumors Identified by 68Ga-DOTANOC and 68Ga-exendin-4 PET/CT in a Patient with Endogenous …

J Xu, X Xu, M Zhang, W Liu, J Chen, S Song - Neuroendocrinology, 2024 - karger.com
Introduction: Insulinomas are the most frequent functional pancreatic neuroendocrine
tumors. In about 10% of cases, insulinomas are associated with hereditary syndrome …

Graph Attention Networks for Drug Combination Discovery: Targeting Pancreatic Cancer Genes with RAIN Protocol

E Parichehreh, AA Kiaei, M Boush, D Safaei… - medRxiv, 2024 - medrxiv.org
Background: Malignant neoplasm of the pancreas (MNP), a highly lethal illness with bleak
outlook and few therapeutic avenues, entails numerous cellular transformations. These …

[HTML][HTML] Editorial for the Special Issue “Molecular Biology in Targeted Radionuclide Therapy Radiopharmaceutical Design”

C Aprile, O Geatti, L Canziani, L Lodola - Current Issues in Molecular …, 2024 - mdpi.com
Targeted radionuclide therapy (TRT) is gaining wide and rapid acceptance in clinical
practice as it can deliver alpha or beta irradiation to a tumor-associated target which may be …

Current Advances in Radioactive Iodine Refractory Differentiated Thyroid Cancer

DF Volpe, C Nappi, E Zampella, E Di Donna, S Maurea… - 2024 - preprints.org
Background: Differentiated thyroid cancer (DTC) patients have an outstanding overall long-
term survival rate, certain subsets of DTC patients have a very high likelihood of disease …